Biomarker and Imaging Core
- Institution
- Yale University, CT
- Principal investigator
- Georges El Fakhri
- Funding
- $741K
- Duration
- 2025–2030
Moonbase score
Still being scored
Abstract
Summary The Imaging and Biomarker Core will facilitate the development and validation of promising biomarkers of AD susceptibility, improve AD risk prediction, and identify promising directions for development of targeted interventions. By creating this Yale ADRC Imaging and Biomarker Core, we leverage the vast experience of Yale’s imaging and biomarker expertise to provide state-of-the-art acquisition and analysis of data and to focus on the development of novel approaches to studying AD. The Imaging Component will i) provide imaging protocols and data analysis strategies to facilitate in-vivo quantification of AD imaging biomarkers, ii) assess, track and validate imaging biomarkers of AD neurobiology, and iii) correlate imaging findings with postmortem neuropathological analysis and biofluid biomarkers, while the Biomarker Component will i) manage the Yale ADRC Biospecimen Repository, ii) assess, track and validate biofluid and tissue biomarkers of AD, and iii) develop and apply cutting-edge mass spectrometric approaches to identify and assess novel AD-associated biomarkers.
LOADING MOONBASE SCORE
Questions for Yale University
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same researchers, same institution, same topic, scored first.
- NIH · Yale University34
Next generation scalable time-of-flight PET - FastSight
Georges El Fakhri · $709K · 2025–2029
- NIH · Yale University31
Deep Learning-Based Treatment Planning for PSMA RPT
Georges El Fakhri · $602K · 2025–2029
- NIH · Yale UniversityNot yet scored
Whole-Body PET/MR scanner
Georges El Fakhri · $2.0M · 2025–2026